Joseph Dal Porto
0009-0003-7520-1018
Genevive, Inc.
1 paper found
Refreshing results…
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors
Missing publications? Search for publications with a matching author name.